recombitek c6 each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units lyophilized powder for injection (im/sc)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) vaccine , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae vaccine (vet.) - lyophilized powder for injection (im/sc) - each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units
recombitek c6/cv 1 dose of 1 ml vaccine contains: lyophilized: canine distemper, canarypox vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least. . . . . . . . . . . . 104.3 tcid50 canine parainfluenza virus, d-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 tcid50 canine coronavirus, k-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 tcid50 canine parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 faid50 liquid: leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 nu leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 nu lyophilized powder for injection (im/sc)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , canine coronavirus (ccv) , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae vaccine (vet.) - lyophilized powder for injection (im/sc) - 1 dose of 1 ml vaccine contains: lyophilized: canine distemper, canarypox vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least. . . . . . . . . . . . 104.3 tcid50 canine parainfluenza virus, d-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 tcid50 canine coronavirus, k-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 tcid50 canine parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 faid50 liquid: leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 nu leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 nu
ingelvac mycoflex formulation: each 1 ml (dose) contains: mesomycoplasma hyopneumoniae (b-3745 isolate, j strain)... >1 rp rp - relative potency emulsion for injection (im)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated mesomycoplasma hyopneumoniae vaccine (vet.) - emulsion for injection (im) - formulation: each 1 ml (dose) contains: mesomycoplasma hyopneumoniae (b-3745 isolate, j strain)... >1 rp rp - relative potency
primodog formulation: each 1 ml (dose) contains: canine parvovirus (cpv-115-780916 strain) ....................>10^5.5 ccid 50 ccid-cell culture infective dose suspension for injection (sc)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live attenuated canine parvovirus (cpv) vaccine (vet.) - suspension for injection (sc) - formulation: each 1 ml (dose) contains: canine parvovirus (cpv-115-780916 strain) ....................>10^5.5 ccid 50 ccid-cell culture infective dose
vaxxitek hvt + ibd + ilt formulation: each dose contains: turkey herpes virus, fc-126, serotype 3 (vhvt317 strain)..........>5640 pfu infectious bursal disease virus (vp2 gene) infectious laryngotracheitis virus (glycoprotein d) pfu - plaque forming unit suspension for injection (in-ovo/sc)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live recombinant turkey herpesvirus (hvt) , infectious bursal disease (ibd) virus , infectious laryngotracheitis (ilt) virus vaccine (vet.) - suspension for injection (in-ovo/sc) - formulation: each dose contains: turkey herpes virus, fc-126, serotype 3 (vhvt317 strain)..........>5640 pfu infectious bursal disease virus (vp2 gene) infectious laryngotracheitis virus (glycoprotein d) pfu - plaque forming unit
neocolipor each 2 ml (dose) contains: escherichia coli k12 (f4ab, f4ac, f4ad factor antigen) escherichia coli k12 (f5 factor antigen) escherichia coli 09 (k9 factor antigen) escherichia coli 0101 (f41 factor antigen) >2.1 sau.* 21.7 sa u.* 21.4 sa u.* 21.7 sa u.* "i sau: .s. to obtain a seroagglutinating antibody titre of 1 log10 inguine pigs suspension for injection (im)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated escherichia coli fimbrial adhesins vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: escherichia coli k12 (f4ab, f4ac, f4ad factor antigen) escherichia coli k12 (f5 factor antigen) escherichia coli 09 (k9 factor antigen) escherichia coli 0101 (f41 factor antigen) >2.1 sau.* 21.7 sa u.* 21.4 sa u.* 21.7 sa u.* "i sau: .s. to obtain a seroagglutinating antibody titre of 1 log10 inguine pigs
enterisol ileitis each 2 ml of reconstituted vaccine (dose) contains: lawsonia intracellularis (b3903 strain) *tcid)- tissue culture infective des 2103.2 tcid50* lyophilized powder for oral solution
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live avirulent lawsonia intracellularis vaccine (vet.) - lyophilized powder for oral solution - each 2 ml of reconstituted vaccine (dose) contains: lawsonia intracellularis (b3903 strain) *tcid)- tissue culture infective des 2103.2 tcid50*
ingelvac circoflex each dose (1 ml) contains: porcine circovirus type 2 orf2 protein *rp-relative potency suspension for injection (im)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated recombinant porcine circovirus type 2 (pcv2) vaccine (vet.) - suspension for injection (im) - each dose (1 ml) contains: porcine circovirus type 2 orf2 protein *rp-relative potency
recombitek c8 formulation: each ml of reconstituted vaccine (dose) contains: canine distemper virus recombinant cp258 (onderstepoort strain).............> 10^6.4 tcid50 canine adenovirus type 2 (toronto a/26/61 strain)...............> 10^4.3 tcid50 canine parvovirus (780916 strain).................> 10^3.3 faid50 canine parainfluenza virus (d-008 strain).................> 10^3.9 tcid50 leptospira interrogans ser. canicola (1503 p4 strain)..................> 200 ftu leptospira interrogans ser. icterohaemorrhagiae (st1518 strain)..................> 200 ftu leptospira interrogans ser. grippotyphosa (sc4397 strain)..................> 300 ftu leptospira interrogans ser. pomona (t262 strain)..................> 300 ftu tcid-tissue culture infective dose faid. fluorescent antibody indoctive dese ftu-formazin turbidity units lyophilized powder for injection (im/sc)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) vaccine , inactivated leptospira interrogans ser. canicola , l. interrogans ser. icterohaemorrhagiae , l. interrogans ser. grippotyphosa , l. interrogans ser. pomona vaccine (vet.) - lyophilized powder for injection (im/sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine distemper virus recombinant cp258 (onderstepoort strain).............> 10^6.4 tcid50 canine adenovirus type 2 (toronto a/26/61 strain)...............> 10^4.3 tcid50 canine parvovirus (780916 strain).................> 10^3.3 faid50 canine parainfluenza virus (d-008 strain).................> 10^3.9 tcid50 leptospira interrogans ser. canicola (1503 p4 strain)..................> 200 ftu leptospira interrogans ser. icterohaemorrhagiae (st1518 strain)..................> 200 ftu leptospira interrogans ser. grippotyphosa (sc4397 strain)..................> 300 ftu leptospira interrogans ser. pomona (t262 strain)..................> 300 ftu tcid-tissue culture infective dose faid. fluorescent antibody indoctive dese ftu-formazin turbidity units
prevexxion rn formulation: each dose contains: marek's disease virus, chimera, serotype 1 (rn1250 strain).....≥952 pfu pfu - plaque forming unit suspension for injection (in-ovo/sc)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live marek's disease virus (mdv) chimera vaccine (vet.) - suspension for injection (in-ovo/sc) - formulation: each dose contains: marek's disease virus, chimera, serotype 1 (rn1250 strain).....≥952 pfu pfu - plaque forming unit